Fresh Tracks Therapeutics Inc Investor Relations Material
Latest events
Q3 2022
Fresh Tracks Therapeutics Inc
Q4 2023
15 Mar, 2024
Q3 2023
13 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Fresh Tracks Therapeutics Inc
Access all reports
Fresh Tracks Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune, inflammatory, and other skin-related diseases. The company's pipeline includes small molecule and biologic drug candidates designed to target the underlying causes of these conditions. Fresh Tracks aims to provide new treatment options that address unmet medical needs in dermatology and immunology. The company serves the healthcare sector, specifically focusing on skin health and immune system disorders. The company is headquartered in Boulder, Colorado, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
FRTX
Country
🇺🇸 United States